Global C-Reactive Protein Rapid Test Market Size By Type (Immunoturbidimetric Assay, ELISA), By Application (Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

lobal C-Reactive Protein Rapid Test Market Report Description

The Global C-Reactive Protein (CRP) Rapid Test Market was valued at USD 2.1 billion in 2023 and is projected to surpass USD 4.3 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2023–2031). The market growth is primarily driven by the increasing prevalence of infectious and chronic diseases, rising demand for point-of-care (POC) diagnostics, and technological advancements in rapid testing methods.

CRP is a key biomarker for detecting acute infections, inflammation, and cardiovascular risks. With a growing need for early diagnosis and timely medical intervention, CRP rapid tests have gained significant adoption in hospitals, clinics, diagnostic centers, and even home-care settings. Additionally, the rising geriatric population and the growing awareness about preventive healthcare are further fueling market expansion.

Drivers

Rising Burden of Chronic and Infectious Diseases

Increasing cases of respiratory infections, sepsis, and autoimmune disorders are driving the need for quick and accurate CRP diagnostics. CRP tests play a crucial role in differentiating bacterial from viral infections, thereby reducing unnecessary antibiotic prescriptions.

Growing Preference for Point-of-Care Testing

CRP rapid tests are widely adopted in primary healthcare and emergency settings due to their ease of use, fast turnaround time, and cost-effectiveness. The shift toward decentralized healthcare is boosting the demand for POC diagnostics.

Technological Advancements in Rapid Testing

Continuous innovations, such as quantitative lateral flow assays and integration with digital readers, have improved the sensitivity and accuracy of CRP rapid tests, further increasing their adoption.

Restraints

Limited Accuracy in Early Stages of Inflammation

While CRP rapid tests are effective, they sometimes lack sensitivity in the early phases of disease onset, which may limit their diagnostic utility.

Regulatory and Quality Concerns

Variability in test quality across different manufacturers and stringent regulatory approvals can pose challenges for market entry and expansion.

Opportunities

Expansion of Home-Based and Remote Testing Solutions

The increasing demand for self-testing kits and telemedicine services presents new opportunities for CRP rapid test manufacturers to develop user-friendly home-based testing solutions.

Growing Adoption in Emerging Economies

Rising healthcare awareness and improving diagnostic infrastructure in emerging markets like India, China, and Brazil are creating lucrative growth opportunities.

Integration with Digital Health Platforms

Linking CRP rapid tests with mobile health apps and electronic medical records can improve data management and remote monitoring, enhancing market penetration.

Market by Test Type Insights

Based on test type, the lateral flow immunoassay segment dominated the market in 2023 due to its simplicity, low cost, and rapid results. However, quantitative CRP rapid tests are expected to witness the fastest growth, driven by the increasing demand for precise measurement of CRP levels for better clinical decision-making.

Market by End-Use Insights

In terms of end-use, hospitals and clinics accounted for the largest revenue share in 2023, owing to the high patient footfall and the critical need for rapid diagnostic solutions. The home-care segment is expected to grow significantly during the forecast period due to the increasing trend of self-monitoring and preventive healthcare.

Market by Regional Insights

North America led the global CRP rapid test market in 2023, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and strong awareness about early diagnostics.

Europe follows closely, driven by favorable reimbursement policies and widespread adoption of POC testing.

Asia-Pacific is anticipated to witness the highest growth rate during the forecast period due to expanding healthcare access, growing awareness, and increasing investments in diagnostic technologies.

Competitive Scenario

Key players in the global C-Reactive Protein Rapid Test market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific Inc., Abaxis Inc., Meril Diagnostics, Orion Diagnostica, Getein Biotech, and SD Biosensor.

These companies are focusing on strategic collaborations, product innovation, and expanding their distribution networks in emerging markets.

In 2024, Abbott introduced an upgraded CRP rapid test integrated with a smartphone app for easy result interpretation.

In 2023, Roche Diagnostics launched a new high-sensitivity CRP rapid assay compatible with both lab and POC settings.

Scope of Work – Global C-Reactive Protein Rapid Test Market

Key Market Developments

2024: Abbott partnered with a leading telemedicine platform to integrate CRP rapid test results into digital patient records for remote consultations.

2023: Roche Diagnostics launched an AI-driven CRP testing solution that enhances result interpretation for clinicians.

2023: SD Biosensor expanded its manufacturing facility in India to cater to the growing demand for POC diagnostics in Asia-Pacific.

FAQs

What is the current market size of the Global C-Reactive Protein Rapid Test Market?

The market was valued at USD 2.1 billion in 2023.

What is the major growth driver of the Global C-Reactive Protein Rapid Test Market?

The key driver is the rising prevalence of infectious and chronic diseases, fueling the demand for rapid and accurate diagnostic solutions.

Which is the largest region during the forecast period in the Global C-Reactive Protein Rapid Test Market?

North America holds the largest share due to advanced healthcare infrastructure and high diagnostic awareness.

Which segment accounted for the largest market share in the Global C-Reactive Protein Rapid Test Market?

The lateral flow immunoassay segment dominated the market in 2023.

Who are the key market players in the Global C-Reactive Protein Rapid Test Market?

Major players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Orion Diagnostica.

Would you like me to also create a visually appealing one-page summary (infographic-style) for this market report? Or should I prepare another report in a similar format for a different market?